Literature DB >> 22534533

The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction.

MyLinh Duong, Reshma Amin, Adrian J Baatjes, Fiona Kritzinger, Ying Qi, Zahida Meghji, Wendy Lou, Hartmut Grasemann, Paul M O'Byrne, Padmaja Subbarao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22534533     DOI: 10.1016/j.jaci.2012.02.051

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

Review 1.  Pediatric exercise-induced bronchoconstriction: contemporary developments in epidemiology, pathogenesis, presentation, diagnosis, and therapy.

Authors:  Christopher Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

Review 2.  Role of cells and mediators in exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; William A Altemeier; Moira L Aitken; William R Henderson
Journal:  Immunol Allergy Clin North Am       Date:  2013-03-29       Impact factor: 3.479

3.  Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine.

Authors:  Radoslaw Gawlik; Marcin Kurowski; Marek Kowalski; Ziemowit Ziętkowski; Andrzej Pokrywka; Hubert Krysztofiak; Jarosław Krzywański; Andrzej Bugajski; Zbigniew Bartuzi
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

4.  Role of leukotrienes in exercise-induced bronchoconstriction before and after a pilot rehabilitation training program.

Authors:  Ibrahim M El-Akkary; Zeinat El-Khouly Abdel-Fatah; Mervat El-Sayed El-Seweify; Gihan A El-Batouti; Ekhlas Abdel Aziz; Abdelnasser I Adam
Journal:  Int J Gen Med       Date:  2013-07-29

Review 5.  Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function.

Authors:  A J Theron; H C Steel; G R Tintinger; C M Gravett; R Anderson; C Feldman
Journal:  J Immunol Res       Date:  2014-05-25       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.